TAOK3 and metabolic dysfunction-associated steatohepatitis: Together, these results suggest that TAOK3 regulates a critical node governing hepatocellular lipid homeostasis and that TAOK3 antagonism could mitigate NAFLD initiation as well as disease progression toward NASH.